GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (NAS:CLLS) » Definitions » Other Current Receivables

CLLS (Cellectis) Other Current Receivables : $17.65 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Cellectis Other Current Receivables?

Cellectis's Other Current Receivables for the quarter that ended in Mar. 2025 was $17.65 Mil.

Cellectis's quarterly Other Current Receivables declined from Sep. 2024 ($16.70 Mil) to Dec. 2024 ($16.32 Mil) but then increased from Dec. 2024 ($16.32 Mil) to Mar. 2025 ($17.65 Mil).

Cellectis's annual Other Current Receivables increased from Dec. 2022 ($16.80 Mil) to Dec. 2023 ($22.56 Mil) but then declined from Dec. 2023 ($22.56 Mil) to Dec. 2024 ($16.32 Mil).

Cellectis Other Current Receivables Historical Data

The historical data trend for Cellectis's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellectis Other Current Receivables Chart

Cellectis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.02 10.71 16.80 22.56 16.32

Cellectis Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.36 16.61 16.70 16.32 17.65

Cellectis Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Cellectis Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Cellectis's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellectis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (NAS:CLLS) » Definitions » Other Current Receivables
Comparable Companies
XPAR:GNFT XPAR:IPH XPAR:DBV XPAR:NANO XPAR:OSE XPAR:MAAT XPAR:TNG XPAR:ADOC XPAR:ALSEN XPAR:IVA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
0WA2:UK ALCLS:France ZVAA:Germany ZVA:Germany ZVAA:Germany
Address
8, rue de la Croix Jarry, Paris, FRA, 75013
Website
https://www.cellectis.com
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.